Skip to main content
Log in

Efficacy and Safety of Pleurodesis Using Platelet-Rich Plasma and Fibrin Glue in Management of Postoperative Chylothorax After Esophagectomy

  • Original Scientific Report
  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Introduction

Chylothorax is by definition a collection of lymphatic fluids in the pleural cavity because of leakage from main thoracic duct or its tributaries. It is an uncommon but serious postoperative complication in esophageal cancer patients. There is no standard therapeutic algorithm for chylothorax because no prospective or randomized trials have yet been performed to evaluate the available treatment options. The aim of this study was to evaluate the efficacy of pleurodesis with a combination of platelet-rich plasma (PRP) and fibrin glue to the treatment of chylothorax after trans-hiatal esophagectomy.

Materials and methods

We randomly allocated 52 consecutive esophageal cancer patients with postoperative chylothorax who did not respond to conservative management to either PRP fibrin glue pleurodesis or surgical thoracic duct ligation. 26 patients in each group were treated with PRP fibrin glue pleurodesis or surgical thoracic duct ligation in order to control chylothorax. Perioperative data, including success rate and complications of both interventions, were analyzed.

Results

Two groups were similar in terms of patients’ demographics and tumor characteristics. All 26 patients in pleurodesis group (100%) and 20 patients in surgery group (76.9%) were successfully treated (p = 0.009). Seven patients (26.92%) in pleurodesis group required a second application of PRP fibrin glue after a week. The mean length of hospital stay was 53.50 ± 16.662 days in surgery group and 36.04 ± 8.224 days in pleurodesis group (p < 0.001). Although mortality rate in surgery group was higher than pleurodesis group, it was not statistically significant (p = 0.1621). There was no significant difference in complications between two groups either. No serious side effect occurred with PRP fibrin glue application.

Conclusion

In conclusion, pleurodesis using PRP and fibrin glue for chylothorax after trans-hiatal esophagectomy was associated with significantly increased success rate, decreased ICU stay, decreased overall hospital stay, and decreased mortality compared with surgical thoracic duct ligation. No patient after PRFG required additional intervention including surgery. Thus, given the improved outcomes with PRFG pleurodesis, this technique may be considered in all patients with postoperative chylothorax after or during conservative management and before proceeding to more invasive interventions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Lagarde SM, Omloo JM, de Jong K, Busch OR, Obertop H, van Lanschot JJ (2005) Incidence and management of chyle leakage after esophagectomy. Ann Thorac Surg 80(2):449–454

    Article  PubMed  Google Scholar 

  2. Shah RD, Luketich JD, Schuchert MJ, Christie NA, Pennathur A, Landreneau RJ et al (2012) Postesophagectomy chylothorax: incidence, risk factors, and outcomes. Ann Thorac Surg 93(3):897–903 discussion-4

    Article  PubMed  PubMed Central  Google Scholar 

  3. Ferguson MK, Little AG, Skinner DB (1985) Current concepts in the management of postoperative chylothorax. Ann Thorac Surg 40(6):542–545

    Article  CAS  PubMed  Google Scholar 

  4. Terzi A, Furlan G, Magnanelli G, Terrini A, Ivic N (1994) Chylothorax after pleuro-pulmonary surgery: a rare but unavoidable complication. Thorac Cardiovasc Surg 42(2):81–84

    Article  CAS  PubMed  Google Scholar 

  5. Miao L, Zhang Y, Hu H, Ma L, Shun Y, Xiang J et al (2015) Incidence and management of chylothorax after esophagectomy. Thorac Cancer 6(3):354–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Paes ML, Powell H (1994) Chylothorax: an update. Br J Hosp Med 51(9):482–490

    CAS  PubMed  Google Scholar 

  7. Macfarlane JR, Holman CW (1972) Chylothorax. Am Rev Respir Dis 105(2):287–291

    CAS  PubMed  Google Scholar 

  8. Maldonado F, Cartin-Ceba R, Hawkins FJ, Ryu JH (2010) Medical and surgical management of chylothorax and associated outcomes. Am J Med Sci 339(4):314–318

    Article  PubMed  Google Scholar 

  9. Doerr CH, Miller DL, Ryu JH (2001) Chylothorax. Semin Respir Crit care Med 22(6):617–626

    Article  CAS  PubMed  Google Scholar 

  10. Maldonado F, Hawkins FJ, Daniels CE, Doerr CH, Decker PA, Ryu JH (2009) Pleural fluid characteristics of chylothorax. Mayo Clin Proc 84(2):129–133

    Article  PubMed  PubMed Central  Google Scholar 

  11. Staats BA, Ellefson RD, Budahn LL, Dines DE, Prakash UB, Offord K (1980) The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin Proc 55(11):700–704

    CAS  PubMed  Google Scholar 

  12. Huggins JT (2010) Chylothorax and cholesterol pleural effusion. Semin Respir Crit Care Med 31(6):743–750

    Article  PubMed  Google Scholar 

  13. McGrath EE, Blades Z, Anderson PB (2010) Chylothorax: aetiology, diagnosis and therapeutic options. Respir Med 104(1):1–8

    Article  PubMed  Google Scholar 

  14. Ryu JH, Tomassetti S, Maldonado F (2011) Update on uncommon pleural effusions. Respirology (Carlton, Vic) 16(2):238–243

    Article  Google Scholar 

  15. Park JG, Aubry MC, Godfrey JA, Midthun DE (2006) Mediastinal lymphangioma: Mayo Clinic experience of 25 cases. Mayo Clin Proc 81(9):1197–1203

    Article  PubMed  Google Scholar 

  16. Mine S, Udagawa H, Kinoshita Y, Makuuchi R (2008) Post-esophagectomy chylous leakage from a duplicated left-sided thoracic duct ligated successfully with left-sided video-assisted thoracoscopic surgery. Interact CardioVasc Thorac Surg 7(6):1186–1188

    Article  PubMed  Google Scholar 

  17. Takuwa T, Yoshida J, Ono S, Hishida T, Nishimura M, Aokage K et al (2013) Low-fat diet management strategy for chylothorax after pulmonary resection and lymph node dissection for primary lung cancer. J Thorac Cardiovasc Surg 146(3):571–574

    Article  PubMed  Google Scholar 

  18. Akin H, Olcmen A, Isgorucu O, Denizkiran I, Dincer I (2012) Approach to patients with chylothorax complicating pulmonary resection. Thorac Cardiovasc Surg 60(2):135–139

    Article  CAS  PubMed  Google Scholar 

  19. Cho HJ, Kim DK, Lee GD, Sim HJ, Choi SH, Kim HR et al (2014) Chylothorax complicating pulmonary resection for lung cancer: effective management and pleurodesis. Ann Thorac Surg 97(2):408–413

    Article  PubMed  Google Scholar 

  20. Zabeck H, Muley T, Dienemann H, Hoffmann H (2011) Management of chylothorax in adults: when is surgery indicated? Thorac Cardiovasc Surg 59(4):243–246

    Article  CAS  PubMed  Google Scholar 

  21. Merrigan BA, Winter DC, O’Sullivan GC (1997) Chylothorax. Br J Surg 84(1):15–20

    Article  CAS  PubMed  Google Scholar 

  22. Browse NL, Allen DR, Wilson NM (1997) Management of chylothorax. Br J Surg 84(12):1711–1716

    Article  CAS  PubMed  Google Scholar 

  23. Fahimi H, Casselman FP, Mariani MA, van Boven WJ, Knaepen PJ, van Swieten HA (2001) Current management of postoperative chylothorax. Ann Thorac Surg 71(2):448–450 discussion50–51

    Article  CAS  PubMed  Google Scholar 

  24. Cerfolio RJ, Allen MS, Deschamps C, Trastek VF, Pairolero PC (1996) Postoperative chylothorax. J Thorac Cardiovasc Surg 112(5):1361–1365 discussion 5–6

    Article  CAS  PubMed  Google Scholar 

  25. Shimizu K, Yoshida J, Nishimura M, Takamochi K, Nakahara R, Nagai K (2002) Treatment strategy for chylothorax after pulmonary resection and lymph node dissection for lung cancer. J Thorac Cardiovasc Surg 124(3):499–502

    Article  PubMed  Google Scholar 

  26. Sriram K, Meguid RA, Meguid MM (2016) Nutritional support in adults with chyle leaks. Nutrition (Burbank, Los Angeles County, Calif) 32(2):281–286

    Article  Google Scholar 

  27. Vargas FS, Milanez JR, Filomeno LT, Fernandez A, Jatene A, Light RW (1994) Intrapleural talc for the prevention of recurrence in benign or undiagnosed pleural effusions. Chest 106(6):1771–1775

    Article  CAS  PubMed  Google Scholar 

  28. Graham DD, McGahren ED, Tribble CG, Daniel TM, Rodgers BM (1994) Use of video-assisted thoracic surgery in the treatment of chylothorax. Ann Thorac Surg 57(6):1507–1511 discussion 11–12

    Article  CAS  PubMed  Google Scholar 

  29. Mares DC, Mathur PN (1998) Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series. Chest 114(3):731–735

    Article  CAS  PubMed  Google Scholar 

  30. Paul S, Altorki NK, Port JL, Stiles BM, Lee PC (2009) Surgical management of chylothorax. Thorac Cardiovasc Surg 57(4):226–228

    Article  CAS  PubMed  Google Scholar 

  31. Griffo S, De Luca G, Stassano P (2010) Chylothorax after abdominal surgery. Gen Thorac Cardiovasc Surg 58(3):159–162

    Article  PubMed  Google Scholar 

  32. Cerfolio RJ (2006) Chylothorax after esophagogastrectomy. Thorac Surg Clin 16(1):49–52

    Article  PubMed  Google Scholar 

  33. Wurnig PN, Hollaus PH, Ohtsuka T, Flege JB, Wolf RK (2000) Thoracoscopic direct clipping of the thoracic duct for chylopericardium and chylothorax. Ann Thorac Surg 70(5):1662–1665

    Article  CAS  PubMed  Google Scholar 

  34. Lyon S, Mott N, Koukounaras J, Shoobridge J, Hudson PV (2013) Role of interventional radiology in the management of chylothorax: a review of the current management of high output chylothorax. Cardiovasc Interv Radiol. 36(3):599–607

    Article  Google Scholar 

  35. Liou DZ, Warren H, Maher DP, Soukiasian HJ, Melo N, Salim A et al (2013) Midodrine: a novel therapeutic for refractory chylothorax. Chest 144(3):1055–1057

    Article  PubMed  Google Scholar 

  36. Kalomenidis I (2006) Octreotide and chylothorax. Curr Opin Pulm Med 12(4):264–267

    Article  PubMed  Google Scholar 

  37. Al-Zubairy SA, Al-Jazairi AS (2003) Octreotide as a therapeutic option for management of chylothorax. Ann Pharmacother 37(5):679–682

    Article  PubMed  Google Scholar 

  38. Kelly RF, Shumway SJ (2000) Conservative management of postoperative chylothorax using somatostatin. Ann Thorac Surg 69(6):1944–1945

    Article  CAS  PubMed  Google Scholar 

  39. Markham KM, Glover JL, Welsh RJ, Lucas RJ, Bendick PJ (2000) Octreotide in the treatment of thoracic duct injuries. Am Surg 66(12):1165–1167

    CAS  PubMed  Google Scholar 

  40. Davis JW, Mackersie RC, Hoyt DB, Garcia J (1994) Randomized study of algorithms for discontinuing tube thoracostomy drainage. J Am Coll Surg 179(5):553–557

    CAS  PubMed  Google Scholar 

  41. Younes RN, Gross JL, Aguiar S, Haddad FJ, Deheinzelin D (2002) When to remove a chest tube? A randomized study with subsequent prospective consecutive validation. J Am Coll Surg 195(5):658–662

    Article  PubMed  Google Scholar 

  42. Dietrich W, Ebell A, Busley R, Boulesteix AL (2007) Aprotinin and anaphylaxis: analysis of 12,403 exposures to aprotinin in cardiac surgery. Ann Thorac Surg 84(4):1144–1150

    Article  PubMed  Google Scholar 

  43. Schenk WG 3rd, Burks SG, Gagne PJ, Kagan SA, Lawson JH, Spotnitz WD (2003) Fibrin sealant improves hemostasis in peripheral vascular surgery: a randomized prospective trial. Ann Surg 237(6):871–876 discussion 6

    PubMed  PubMed Central  Google Scholar 

  44. Wenger FA, Szucsik E, Hoinoiu BF, Cimpean AM, Ionac M, Raica M (2015) Circular anastomotic experimental fibrin sealant protection in deep colorectal anastomosis in pigs in a randomized 9-day survival study. Int J Colorectal Dis 30(8):1029–1039

    Article  CAS  PubMed  Google Scholar 

  45. Asadi M, Alamdari DH, Rahimi HR, Aliakbarian M, Jangjoo A, Abdollahi A et al (2014) Treatment of life-threatening wounds with a combination of allogenic platelet-rich plasma, fibrin glue and collagen matrix, and a literature review. Exp Ther Med 8(2):423–429

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Akhundov K, Pietramaggiori G, Waselle L, Darwiche S, Guerid S, Scaletta C et al (2012) Development of a cost-effective method for platelet-rich plasma (PRP) preparation for topical wound healing. Ann Burns Fire Disasters 25(4):207–213

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This study was supported by Grants from Mashhad University of Medical Sciences (MUMS).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mehdi Asadi.

Ethics declarations

Conflict of interest

There are no conflicts of interest in all authors.

Disclosures

This study was a thesis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Alamdari, D.H., Asadi, M., Rahim, A.N. et al. Efficacy and Safety of Pleurodesis Using Platelet-Rich Plasma and Fibrin Glue in Management of Postoperative Chylothorax After Esophagectomy. World J Surg 42, 1046–1055 (2018). https://doi.org/10.1007/s00268-017-4242-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-017-4242-x

Navigation